Enanta Pharmaceuticals In... (ENTA)
5.30
-0.22 (-3.99%)
At close: Apr 01, 2025, 3:59 PM
5.36
1.07%
After-hours: Apr 01, 2025, 07:50 PM EDT
Enanta Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 37.23M | 85.39M | 43.99M | 57.21M | 87.13M | 51.23M | 63.9M | 65.67M | 16.58M | 21.73M | 30.7M | 8.86M | 10.51M | 6.84M |
| Short-Term Investments | 210.95M | 284.52M | 205.24M | 186.8M | 299.52M | 284.01M | 244.83M | 157.99M | 193.51M | 123.48M | 60.06M | 92.62M | 33.25M | 16.49M |
| Long-Term Investments | n/a | n/a | 29.29M | 108.42M | 32.63M | 65.01M | 16.39M | 70.04M | 32.12M | 64.24M | 41M | 10.7M | 1.66M | n/a |
| Other Long-Term Assets | 3.45M | 4.77M | 4.66M | 700K | 700K | 700K | 700K | 608K | 608K | 608K | 436K | 436K | 2.59M | 463K |
| Receivables | 6.65M | 39.62M | 49.04M | 60.83M | 23.49M | 51.31M | 67.2M | 10.61M | 12.84M | 15.72M | 4.49M | 1.59M | 2.94M | 261K |
| Inventory | n/a | n/a | n/a | -37.26M | n/a | n/a | n/a | n/a | n/a | 1.00 | 1.00 | n/a | 1.00 | n/a |
| Other Current Assets | 45.02M | 13.26M | n/a | n/a | 26.7M | 15.3M | 4.45M | 3.54M | 9.23M | 9.71M | 12.72M | 1.64M | n/a | 1.14M |
| Total Current Assets | 299.85M | 422.79M | 311.71M | 319.02M | 436.84M | 401.85M | 380.39M | 237.82M | 232.16M | 170.64M | 107.97M | 104.71M | 47.31M | 25.1M |
| Property-Plant & Equipment | 73.35M | 34.71M | 29.75M | 10.65M | 15.62M | 10.93M | 8.37M | 8.05M | 8M | 5.89M | 1.8M | 1.12M | 611K | 534K |
| Goodwill & Intangibles | n/a | n/a | -5.18M | -2.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 76.8M | 39.48M | 63.7M | 119.77M | 49.3M | 87.98M | 33.84M | 88.82M | 49.12M | 75.37M | 47.44M | 12.26M | 4.85M | 997K |
| Total Assets | 376.65M | 462.27M | 375.41M | 438.79M | 486.13M | 489.83M | 414.23M | 326.64M | 281.28M | 246.01M | 155.41M | 116.97M | 52.16M | 26.1M |
| Account Payables | 8M | 4.1M | 6M | 9.54M | 5.74M | 6.69M | 4.75M | 3.71M | 3.38M | 1.54M | 1.87M | 1.48M | 1.85M | 566K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.3M | n/a | 1.2M | n/a | 10K | 17K | n/a |
| Short-Term Debt | 1.52M | n/a | 2.89M | 4.2M | 4.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 46.48M | 46.38M | 11.61M | 12.13M | 5.12M | n/a | n/a | 9.22M | n/a | 2.51M | n/a | n/a | n/a | n/a |
| Total Current Liabilities | 57.53M | 62.79M | 29.83M | 36.17M | 24.16M | 22.61M | 16.02M | 20.98M | 7.89M | 6.7M | 4.75M | 4.53M | 5.73M | 2.15M |
| Long-Term Debt | n/a | n/a | n/a | n/a | 1.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 136.36M | 161.51M | 1.88M | 2.06M | 1.08M | 4.53M | 4.23M | 3.6M | 2.99M | 2.62M | 2.02M | 1.98M | 2.5M | 155.91M |
| Total Long-Term Liabilities | 190.3M | 182.75M | 24.25M | 3.19M | 6.39M | 4.73M | 4.52M | 3.98M | 3.45M | 3.15M | 2.02M | 1.98M | 2.5M | 155.91M |
| Total Liabilities | 247.84M | 245.54M | 54.08M | 39.36M | 30.55M | 27.34M | 20.55M | 24.96M | 11.34M | 9.86M | 6.76M | 6.5M | 8.23M | 158.06M |
| Total Debt | 55.47M | 26.51M | 25.26M | 5.33M | 8.1M | 200K | 293K | 458K | 531K | 598K | 200K | n/a | n/a | n/a |
| Common Stock | 212K | 211K | 208K | 202K | 201K | 197K | 194K | 191K | 190K | 187K | 188K | 181K | 13K | 53K |
| Retained Earnings | -323.04M | -207M | -73.18M | 48.58M | 127.57M | 163.74M | 117.36M | 45.36M | 27.65M | 5.98M | -73.01M | -107.45M | -115.37M | -132M |
| Comprehensive Income | 302K | -1.17M | -3.72M | -382K | 844K | 146K | -398K | -112K | 19K | 33K | -100K | -2K | 10K | -1K |
| Shareholders Equity | 128.81M | 216.74M | 321.33M | 399.43M | 455.58M | 462.49M | 393.68M | 301.68M | 269.94M | 236.16M | 148.65M | 110.47M | 43.93M | -131.96M |
| Total Investments | 210.95M | 284.52M | 234.52M | 295.21M | 332.15M | 349.02M | 261.22M | 228.03M | 225.63M | 187.72M | 101.07M | 103.32M | 34.91M | 16.49M |